EverSource Wealth Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.4K Sell
126
-98
-44% -$4.11K ﹤0.01% 3080
2026
Q1
$7.21K Buy
224
+77
+52% +$2.85K ﹤0.01% 3089
2025
Q4
$6.19K Sell
147
-167
-53% -$6.73K ﹤0.01% 3030
2025
Q3
$10.8K Sell
314
-32
-9% -$918 ﹤0.01% 2781
2025
Q2
$9.35K Sell
346
-15,604
-98% -$452K ﹤0.01% 2852
2025
Q1
$473K Buy
15,950
+15,832
+13,417% +$603K 0.03% 394
2024
Q4
$4.67K Buy
118
+56
+90% +$2.12K ﹤0.01% 2377
2024
Q3
$2.11K Buy
62
+27
+77% +$760 ﹤0.01% 2529
2024
Q2
$840 Buy
35
+25
+250% +$526 ﹤0.01% 2773
2024
Q1
$196 Sell
10
-52
-84% -$1.27K ﹤0.01% 2799
2023
Q4
$1.71K Buy
+62
New +$1.5K ﹤0.01% 2217

Other funds holding VCYT

EverSource Wealth Advisors's VCYT Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Veracyte (VCYT) stake by 44% in Q2 2026, selling an estimated $4.11K and leaving 126 shares worth $7.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3080.

EverSource Wealth Advisors first reported a position in VCYT in Q4 2023 and has held it in 11 quarters since. The position peaked at $473K in Q1 2025. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • EverSource Wealth Advisors held 126 shares of Veracyte worth $7.4K as of Q2 2026.
  • EverSource Wealth Advisors sold 98 Veracyte shares in Q2 2026, an estimated $4.11K.
  • Veracyte made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3080 holding.
  • EverSource Wealth Advisors first reported a position in Veracyte in Q4 2023 and has held it in 11 quarters since.
  • EverSource Wealth Advisors's Veracyte position peaked at $473K in Q1 2025.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.